Objectives: To investigate whether removing lactose from milk delays bowel function in lactose-tolerant women. We also examined how well the participants' subjective evaluation of the stool consistency according to the Bristol Stool Form Scale correlated with values obtained by dry matter analysis and penetrometry. Subjects and methods: A randomized double-blind cross-over trial. Thirty-three lactose-tolerant women consumed, in random order, 800 ml of lactose-free or ordinary milk per day for 2 weeks, with their main meal, but otherwise followed a lactose-free diet. The subjects estimated stool consistency according to the Bristol Stool Form Scale, registered stool frequency and gastrointestinal symptoms and collected stool samples. Results: The mean intake of lactose was 3.5 and 38.4 g/day during the lactose-free and the ordinary milk periods, respectively. There were no statistically significant differences between the lactose-free and the ordinary milk periods in stool frequency, gastrointestinal symptoms, stool hardness or faecal dry matter. Faecal pH was lower during the lactose-free milk period than in the ordinary milk period. The subjective estimation of stool hardness correlated well with the values obtained by dry matter analysis and penetrometry. Conclusions: Lactose-free milk does not delay bowel function in lactose-tolerant women. The Bristol Stool Form Scale is a useful method of evaluating stool hardness.
Introduction
Lactose is a disaccharide found only in milk. To be absorbed, lactose needs to be hydrolysed into glucose and galactose by the brush border enzyme lactase. Lactose malabsorption is a very common condition, characterized by lactase deficiency. (Arola and Tamm, 1994) . However, the rate and efficiency of lactose metabolism is dependent not only on the activity of lactase, but also on the amount of lactose ingested, on the gastrointestinal transit time, visceral sensitivity, the presence of functional gastrointestinal disorders and the capability of the intestinal microflora to ferment lactose (Vesa et al., 2000) . Thus, a varying amount of undigested lactose reaches the colon both in normolactasic and in lactase-deficient subjects (Bond and Levitt, 1976) , and this may have an effect on bowel function.
In lactase-deficient subjects, lactose may cause gastrointestinal symptoms such as flatulence and diarrhoea, and this condition is known as lactose intolerance. It has been demonstrated that undigested lactose causes an osmotic load, which leads to diarrhoea (Christopher and Bayless, 1971) . In addition, colonic fermentation of lactose may play a role in the symptoms of lactose intolerance (He et al., 2006) . Malabsorbed lactose increases the production of short-chain fatty acids in the colon (Holtug et al., 1992; He et al., 2006) and reduces intestinal pH (Christopher and Bayless, 1971) , and this increases the motility of the gastrointestinal tract (Piche et al., 2000) .
There have been only a few small-scale studies testing the laxative effect of milk lactose in lactose-tolerant persons. In a double-blind, randomized clinical trial, the effect of 20 and 40 g/day of milk lactose was studied in 15 elderly constipated subjects (Kleessen et al., 1997) . Both doses had a slight laxative effect, but the effect of the smaller dose was more marked. The researchers suggested that lactose can be used in the treatment of constipation (Kleessen et al., 1997) . The study of Ewe et al. (1995) does not, however, support the effectiveness of lactose in treating constipation. No change in colonic transit, stool weight or stool consistency was observed when 10 healthy persons ingested 45 g of lactose daily.
Milk products have an important role in the diet of many nationalities, particularly in the northern European countries. The prevalence of lactose intolerance generates a demand for specific low-lactose and lactose-free dairy products. The use of these products might affect bowel function and stool consistency, since the possible laxative effect is eliminated with the lactose.
The primary aim of this study was to investigate whether milk from which lactose has been completely removed by chromatography delays gastrointestinal function or hardens stool consistency in healthy women. The secondary aim was to examine how well the participants' subjective evaluation of stool consistency, according to the Bristol Stool Form Scale, correlates with values obtained by two different methods, that is, dry matter analysis and penetrometry.
Subjects and methods
Thirty-six healthy women applied for the study. The subjects had to be regular milk drinkers and be lactose-tolerant, that is, they should not experience any symptoms after drinking milk. The other inclusion criteria were: female, age 18-64 years, normal weight (body mass index (BMI) between 20.0 and 24.9), normal bowel function (bowel movements between three times per day and three times per week), no antibiotic treatment or laxatives during the 4 weeks before the study. The subjects were not allowed to use any medical treatment affecting bowel function. The inclusion criteria were checked by means of a questionnaire before the study. Thirty-five subjects fulfilled these criteria and were recruited for the study. At the beginning of the study, there was one dropout because of antibiotic treatment and one because of pregnancy, so the final number of subjects was 33. The subjects gave their written consent to the study and the study protocol was approved by the Ethical Committee of the Faculty of Agriculture and Forestry, University of Helsinki.
This study was a randomized, double-blind, cross-over study, and lasted 6 weeks. After a 1-week run-in period, each subject participated in two 2-week treatment periods (lactose-free milk and ordinary milk) in random order. There was a 1-week wash-out period between the treatments. The subjects were instructed to maintain their normal lifestyle and dietary habits. To enable us to observe a significant difference in lactose intake between the treatment periods, the subjects were asked to follow a lactose-free diet and were given verbal and written advice on how to choose lactosefree foods. The maximal lactose intake permitted from foods other than the treatment milks was 2 g/day. The dietary intakes of lactose and other factors that may have an effect on bowel function (fibre, fluid) were assessed during the runin and the treatment periods by means of a 3-day food record (2 working days and 1 weekend day).
Study milks
The study milks were an ordinary fat-free milk (control milk) and a lactose-free milk prepared from the ordinary fat-free milk by a chromatographic method (Harju, 1987) . The lactose contents of the ordinary milk and the lactose-free milk were 4.9 and 0.05%, respectively. Otherwise the nutritional value of the milks was roughly similar. The test milks were ultra high temperature (UTH) treated (1431C for 5 s) for preservation, packed in identical 200-ml cartons and labelled with codes. The test milks were prepared at Valio Ltd, Turenki, Finland. The volunteers were advised to drink four cartons of milk (800 ml) per day during the treatment periods, one at breakfast, two at lunch and one with an evening snack. The milk was consumed either as it was or added to a drink or a food. The daily portions of the control milk and the lactosefree milk contained 39.2 and 0.4 g of lactose, respectively. The intention was that the intake of lactose should be at least 39.2 g/day during the control-milk period and at most, 2.4 g/ day during the lactose-free milk period.
Faecal collection and stool sample measurement During the run-in and treatment periods, the first defecation of the day was collected on three consecutive days in separate plastic bags labelled with codes and dates, and the bags were put into plastic containers. If a subject did not defecate on the day when she should have collected her stool, the sample of that day was marked as missing. Thus, every subject collected 0-3 stools during both the run-in and treatment periods. The samples were kept and measured separately and the results were calculated from the mean of the samples, which the subjects were able to collect. During the run-in period, the first defecation of the day was collected on the Wednesday, Thursday and Friday, and the stools were frozen immediately. During the treatment periods, the first defecation of the day was collected on the Wednesday, Thursday and Friday of the second week. These samples were kept cold at þ 41C for 1-3 days and were moved to room temperature 2 hours before the measurement of stool hardness, which was measured with a penetrometer PNR 6 No18-000 (Sommer & Runge KG, Berlin, Germany) as described by Exton-Smith et al. (1975) with some modifications. The total moving weight was 475 g and it was allowed to drop into the stool for 5 s. Four readings were taken at different points of the stool, and the stool hardness was defined as the mean of these measurements. However, if the stool sample was very small, it was not possible to measure its hardness.
After the measurement of stool hardness, the samples were frozen at À201C. Two days before the analysis of dry weight and pH, the samples were unfrozen at þ 41C for 2 days. For dry weight analysis, 5-10 g of stool sample was placed in a preweighed aluminium pan, weighed, and dried in an oven at a temperature of 105-1101C (WTB Binder E28, Laboratechnik GmbH, Tuttlingen, Germany) for 20-24 h, and cooled off in an exsiccator for 20-24 h. The sample was weighed and the result was defined as the mean of two different measurements. The percentage of faecal dry matter was counted as follows: dry matter (%) ¼ dry weight/wet weight Â 100%. Stool pH was determined with a pH meter (Orion pH meter model 420A, Orion Research Ltd, Boston, MA, USA). pH was measured from two different places in the sample and the result was defined as the mean of these two measurements.
Study diary
Each day of the study, the subjects filled in a study diary about their bowel movements. The subjects reported the time of each defecation and subjective observations on stool colour (darker than usual, normal, lighter than usual). The stool consistency was estimated by the seven-point Bristol Stool Form Scale (O'Donnell et al., 1990) , by which stools are scored according to cohesion and surface cracking: 1 ¼ separate hard lumps like nuts, 2 ¼ sausage-shaped but lumpy, 3 ¼ like a sausage but with cracks on its surface, 4 ¼ like a sausage, smooth and soft, 5 ¼ soft blobs with clearcut edges, 6 ¼ fluffy pieces with ragged edges, a mushy stool, 7 ¼ watery, no solid pieces. Once a day, they also reported on the presence and severity of gastrointestinal symptoms: abdominal pain, flatulence, abdominal bloating and rumbling. The symptoms were graded from 0 to 3: 0 ¼ no symptoms, 1 ¼ mild, 2 ¼ moderate, 3 ¼ strong symptoms. In addition, information was collected on compliance with the milk drinking, intake of fluid and all the factors that might influence bowel function.
Statistical analyses
The sample size calculations were based on stool frequency per week. It was defined that the clinically important treatment difference would be one defecation per week. It was calculated that in a cross-over study, a minimum of 34 subjects was needed in order for the differences between treatments to be statistically significant at a significance level of 5% and a power of 80%. The assumed standard deviation of differences was 2.
The primary variable was stool frequency (times/week). The secondary variables were symptom score and variables indicating stool hardness. The symptom score was a sum of gastrointestinal symptoms (abdominal pain, flatulence, abdominal bloating and rumbling) per week (sum of symptoms, possible range 0-84). Stool hardness, faecal dry matter and stool pH were calculated as a mean of the samples (0-3) collected during each period. Analysis of variance for repeated measures was applied in order to study the treatment difference, period effect and interaction between treatment and period. The results are given as mean with a 95% confidence interval for both study milks and for the difference between them. In cases of significant interaction, only the first treatment period was included in the analysis.
The associations between subjective evaluations of stool consistency (Bristol Stool Form Scale) and results of dry matter analysis and penetrometry were assessed using repeated observations, from 1 to 6 per subject (Bland and Altman, 1995) . The correlation coefficients and the regression lines were estimated accordingly. Data were analysed with SPSS (version 14.0; SPSS Inc., Chicago, IL, USA)
Results
Thirty-three volunteers completed the study. The mean age was 28 years (range 18-55 years). There were no significant changes in physical activity during the study, and no medical treatment affecting bowel habits (data not shown).
According to the study diaries, compliance with the milks was good. The mean compliance was 95 and 94% for the control and the lactose-free milks, respectively. Mean milk consumption was 290, 760 and 750 ml/d during the run-in, the control-milk and the lactose-free milk periods, respectively. Table 1 shows the intakes of lactose, fluid and fibre during the study. After the run-in and the lactose-free period, three subjects and one subject, respectively did not return their food diaries, and thus, the intakes during those periods have been measured from 30 and 32 subjects, respectively. The mean intake of lactose was significantly higher during the control-milk period than during the lactose-free milk period (Po0.001). The mean difference in the intake of lactose between the treatment periods was 34.9 g/day, which was almost as high as planned. The mean fibre intake did not differ between the treatment periods, but the mean fluid intake was significantly higher during the control-milk period than in the lactose-free milk period (Po0.001).
Stool frequency and gastrointestinal symptoms during the run-in, control-milk and lactose-free milk periods are shown in Table 2 . Stool frequency increased slightly during the treatment periods compared to the run-in period, but there were no differences in stool frequency between the lactosefree and the control-milk periods. During the study, gastrointestinal symptoms were common, the most common being flatulence. One subject during the run-in and lactose-free periods did not report on the presence and severity of gastrointestinal symptoms and thus these results are calculated from 32 subjects. There were no statistically significant differences in the sum of symptoms between the treatment periods (Table 2 ). Compared to the run-in period, the sum of symptoms was significantly higher during the control-milk period (Po0.001) and the lactose-free milk period (P ¼ 0.001) (data not shown). Table 3 shows that there were no statistically significant differences in stool hardness or faecal dry matter between the treatment periods. The mean faecal pH was 6.8 both in those subjects who started with the control milk and in those who started with the lactose-free milk (data not shown). Because of significant carry-over (P ¼ 0.032) and period (P ¼ 0.019) effects in stool pH, only the first periods were taken into account. *Significant difference between the treatment periods.
During the study, there were significant carryover and period effects in faecal pH, and therefore in both groups only, the results of the first treatment periods were taken into account. Faecal pH was significantly higher during the control-milk period than during the lactose-free milk period (Table 3) . The association between the subjective evaluation of the stool consistency and the values obtained by penetrometer and faecal dry analysis was calculated from 33 subjects, and 132 and 168 stool samples, respectively (Figure 1 ). When the variation among subjects was removed, there was a significant correlation between the subjective stool form score and stool hardness (r ¼ 0.39, Po0.001). The estimated regression line for stool hardness was 22.68 þ 10.68 Â subjective stool consistency. The subjective stool form score also correlated with faecal dry matter (r ¼ À0.44, Po0.001), and the corresponding regression line for faecal dry matter was 33.79-1.74 Â subjective stool consistency.
Discussion
This randomized double-blind, cross-over study showed that milk from which lactose had been completely removed did not affect bowel function in healthy women. Only women were recruited for the present study, because it has been suggested that bowel function differs between the sexes. In several studies, women have had harder stools than men (Degen and Phillips, 1996a) , and colonic transit has been faster in men than in women (Hinds et al., 1989; Degen and Phillips, 1996b; Chan et al., 2004) . The menstrual cycle was not taken into account, because several studies have confirmed that sex hormones do not have any major effect on bowel frequency, stool weight (Kamm et al., 1989) or transit time (Hinds et al., 1989; Turnbull et al., 1989; Degen and Phillips, 1996b) .
It has been found that lactose-tolerant subjects may fail to absorb some of the ingested lactose. In an earlier study, 0-8% of lactose was not absorbed in lactose-tolerant subjects (Bond and Levitt, 1976) . Thus, lactose may have a slight laxative effect in the gastrointestinal tract in healthy subjects (Kleessen et al., 1997) . In the same article, the authors reported that stool frequency increased and the percentage of faecal dry matter decreased in lactose-tolerant elderly volunteers in response to the ingestion of 20-40 g of lactose per day. On the contrary, we found no statistically significant differences in stool frequency and the percentage of faecal dry matter between the lactose-free milk period (lactose intake 3.5 g/day) and the control-milk period (lactose intake 38.4 g/day). Our result is similar to that of Ewe et al. (1995) , who reported that lactose did not have any laxative effect in lactose-tolerant people.
Compared to the run-in period, stool frequency increased slightly during both milk periods. Similarly, Vesa et al. (1997) noted that ingestion of milk without consideration of its lactose content increased the number of stools compared to the milk-free period. The authors suggested that this could be due to the increased ingestion of fluid from the test milks. In the present study, the fluid intake cannot explain the increase in stool frequency during the treatment periods, because it was significantly higher during the control-milk period than in the lactose-free period, during which it was lower than during the run-in period. Fibre intake, which may affect stool frequency (Dukas et al., 2003) , was also similar during both periods. It is possible that some other dietary factor or change in lifestyle may have had a slight effect on bowel habits, but it should be noted that the increase in stool frequency was neither statistically nor clinically significant.
In our study, stool hardness was measured with a penetrometer, which has proved to be a reliable method for measuring stool hardness (Exton-Smith et al., 1975) . We found no significant differences in stool hardness between the treatment periods. Our subjects also estimated their stool consistency by the seven-point Bristol Stool Form Scale, and the stool score correlated well with the values obtained by penetrometry and dry matter analysis. Earlier, O'Donnell et al. (1990) found that the Bristol Stool Form Scale correlated clearly with whole-gut transit. Our study confirmed that the Bristol Stool Form Scale is also a useful method of evaluating stool hardness and faecal dry matter.
It has been reported that lactose reduces faecal pH in both lactose-tolerant (Holtug et al., 1992) and -intolerant subjects ( Christopher and Bayless, 1971; Briet et al., 1997) . However, Kleessen et al. (1997) found no differences in faecal pH after ingestion of 20 or 40 g of lactose per day. In the present study, there were significant carryover and period effects in faecal pH, and therefore only the results of the first treatment periods were taken into account. Surprisingly, faecal pH was significantly higher during the lactose period than during the lactose-free period. Lactose is not the only factor affecting faecal pH; dietary fibre (Van Munster and Nagengast, 1993; Nakao et al., 2002) and transit time (Lewis and Heaton, 1997) , for instance, may also have an effect. In our study, there were no differences in fibre intake between the treatment periods. Transit time was not measured, but stool hardness, which correlates with it (Lewis and Heaton, 1997), did not change during the study. The effect of lactose on faecal pH needs to be studied in larger and longer trials.
In our study, gastrointestinal symptoms were common, but the symptom scores were fairly low. The symptoms were significantly more common during the treatment periods, when the milk intake was 750-760 ml/day, than during the run-in period, when the milk intake was only 290 ml/day. However, there were no differences in gastrointestinal symptoms between the lactose-free and the control-milk periods. Thus, lactose cannot be the reason for the increased symptoms. Similarly, several well-controlled studies have demonstrated that gastrointestinal symptoms after milk intake quite often occur independently of lactose intake (Rosado et al., 1987; Johnson et al., 1993; Vesa et al., 1996) . It has been suggested that milk hypersensitivity in adults, which may be more common than previously thought, may cause gastrointestinal symptoms after milk intake (Pelto et al., 1998) . It is also well known that physiological factors, which are difficult to control, affect gastrointestinal symptoms (Vesa et al., 1996) .
In conclusion, our study confirms that removing lactose from milk does not affect bowel function in healthy women. It seems that the dose of lactose chosen in this trial and ingested with meals does not have a laxative effect in lactosetolerant subjects. Our study also showed that the subjective estimation of stool consistency correlates well with values obtained by dry matter analysing and penetrometry. Thus, the Bristol Stool Form Scale is a useful method of evaluating stool hardness. The effect of lactose on faecal pH and the reason for the increased gastrointestinal symptoms observed during the milk periods are two points that remain to be clarified by larger studies.
